# A National Study for Blood Based Response Monitoring of B-cell Lymphoma Patients

> **NCT04139252** · — · UNKNOWN · sponsor: **Stichting Hemato-Oncologie voor Volwassenen Nederland** · enrollment: 250 (actual)

## Conditions studied

- NHL

## Interventions

- **OTHER:** No intervention

## Key facts

- **NCT ID:** NCT04139252
- **Lead sponsor:** Stichting Hemato-Oncologie voor Volwassenen Nederland
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-03-17
- **Primary completion:** 2023-06
- **Final completion:** 2023-06
- **Target enrollment:** 250 (ACTUAL)
- **Last updated:** 2023-04-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04139252

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04139252, "A National Study for Blood Based Response Monitoring of B-cell Lymphoma Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04139252. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*